FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Kelsen

Research Profile

Disorders

Procedures

Chemicals & Drugs

Activities & Behaviors

Drug Evaluation

Concepts & Ideas

Co-author Network

Publications

TOP 3
Yelena Y Janjigian; David P Kelsen
Genomic dysregulation in gastric tumors.
Elizabeth Smyth; Vivian E Strong; Marinela Capanu; Daniel G Coit; David P Kelsen; Heiko Schöder; Manish A Shah
A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.
Yelena Janjigian; David P Kelsen; Claudia Pauligk; E Robinson; Manish A Shah; K Steinmetz; L J Tafe; Laura H Tang; D Werner; Hans-Michael Altmannsberger; Elke Jäger; Salah-Eddin Al-Batran
Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Kelsen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Yelena Y Janjigian; David P Kelsen
Genomic dysregulation in gastric tumors.
Journal of surgical oncology 2013;107(3):237-42.
2012: Elizabeth Smyth; Vivian E Strong; Marinela Capanu; Daniel G Coit; David P Kelsen; Heiko Schöder; Manish A Shah
A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.
Cancer 2012;118(22):5481-8.
2012: Yelena Janjigian; David P Kelsen; Claudia Pauligk; E Robinson; Manish A Shah; K Steinmetz; L J Tafe; Laura H Tang; D Werner; Hans-Michael Altmannsberger; Elke Jäger; Salah-Eddin Al-Batran
Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(10):2656-62.
2012: Andrew S Epstein; Stuart Gardos; David P Kelsen; Marinela Capanu; Christopher Crosbie; Brian Denton; Manish A Shah; Gerald A Soff; Eileen M O'Reilly
Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancer.
Cancer 2012;118(12):3053-61.
2012: David H Ilson; David P Kelsen; Geoffrey Y Ku; Bruce D Minsky; Nabil Rizk; Valerie Rusch; Manish Shah; Laura Tang; Jenny Campbell; Marinela Capanu; Manjit Bains
Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer.
Cancer 2012;118(11):2820-7.
2012: Michael Postow; Manish A Shah; Ali Shamseddine; Sally Tamraz; Ashwaq Al Olayan; Celina Ang; Aghiad El-Kutoubi; Abdul-Rahman Jazieh; David P Kelsen; Maeve Lowery; Mohamed Naghy; Eileen M O'Reilly; Ghassan K Abou-Alfa
A man with Klinefelter's syndrome and new abdominal distension: a discussion of evaluation and management.
Journal of gastrointestinal cancer 2012;43(2):314-8.
2011: Manish A Shah; Laura Tang; John J Wright; Margaret M Kemeny; Hedy L Kindler; Derek G Power; Marinela Capanu; Kyle D Holen; David H Ilson; David P Kelsen
A multicenter, phase II study of bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma.
Investigational new drugs 2011;29(6):1475-81.
2011: R C Fields; Mithat Gonen; Karyn A Goodman; David H Ilson; David P Kelsen; Nabil P Rizk; Murray F Brennan; Daniel G Coit; Vivian E Strong; Laura H Tang; Manish A Shah
Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma.
British journal of cancer 2011;104(12):1840-7.
2011: Ghassan K Abou-Alfa; Paul B Chapman; Jonas Feilchenfeldt; Murray F Brennan; Marinela Capanu; Bolorsukh Gansukh; Gria Jacobs; Adrah Levin; Deirdre Neville; David P Kelsen; Eileen M O'Reilly
Targeting mutated K-ras in pancreatic adenocarcinoma using an adjuvant vaccine.
American journal of clinical oncology 2011;34(3):321-5.
2011: Manish A Shah; Raya Khanin; Laura Tang; Yelena Y Janjigian; David S Klimstra; Hans Gerdes; David P Kelsen
Molecular classification of gastric cancer: a new paradigm.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(9):2693-701.
2011: Yelena Y Janjigian; Laura H Tang; Daniel G Coit; David P Kelsen; Todd D Francone; Martin R Weiser; Suresh C Jhanwar; Manish A Shah
MET expression and amplification in patients with localized gastric cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(5):1021-7.
2011: Manish A Shah; Minaxi Jhawer; David H Ilson; Robert A Lefkowitz; Edric Robinson; Marinela Capanu; David P Kelsen
Phase II study of modified docetaxel, cisplatin, and fluorouracil with bevacizumab in patients with metastatic gastroesophageal adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(7):868-74.
2011: Maeve A Lowery; Emmy Ludwig; Peter J Allen; David R D'Adamo; Yelena Y Janjigian; David P Kelsen; Robert C Kurtz; Mark Robson; Erin Salo-Mullen; Zsofia Kinga Stadler; Kenneth H Yu; Eileen M O'Reilly
An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions.
The oncologist 2011;16(10):1397-402.
2010: Manish A Shah; Marinela Capanu; Gerald A Soff; T Asmis; David P Kelsen
Risk factors for developing a new venous thromboembolism in ambulatory patients with non-hematologic malignancies and impact on survival for gastroesophageal malignancies.
Journal of thrombosis and haemostasis : JTH 2010;8(8):1702-9.
2010: Derek G Power; David P Kelsen; Manish A Shah
Advanced gastric cancer--slow but steady progress.
Cancer treatment reviews 2010;36(5):384-92.
2010: Manish A Shah; David P Kelsen
Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease.
Journal of the National Comprehensive Cancer Network : JNCCN 2010;8(4):437-47.
2009: Minaxi Jhawer; Daniel G Coit; Murray F Brennan; Li-Xuan Qin; Mithat Gonen; David S Klimstra; Laura H Tang; David P Kelsen; Manish A Shah
Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation.
American journal of clinical oncology 2009;32(4):356-62.
2009: William P Tew; Delia Radovich; Eileen O'Reilly; Gary K Schwartz; Deborah Schrag; Leonard B Saltz; David P Kelsen; Stacey Kepler; David H Ilson
Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancer.
Investigational new drugs 2009;27(4):366-73.
2009: Geoffrey Y Ku; Eileen O'Reilly; Leonard B Saltz; Deborah Schrag; ROBERT G MAKI; David P Kelsen; David H Ilson
Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of irinotecan in advanced solid tumors.
Cancer investigation 2009;27(4):402-6.
2009: Gary K Schwartz; Kathryn Winter; Bruce D Minsky; Christopher Crane; P John Thomson; Pramila Anne; Howard Gross; Christopher Willett; David P Kelsen
Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric cancer (RTOG-0114).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(12):1956-62.
2009: Manisha H Shah; Kimberly A Varker; Minden Collamore; James A Zwiebel; Daniel G Coit; David P Kelsen; Ki Young Chung
G3139 (Genasense) in patients with advanced merkel cell carcinoma.
American journal of clinical oncology 2009;32(2):174-9.
2009: Derek G Power; Mark A Schattner; Hans Gerdes; Baruch Brenner; Arnold J Markowitz; Marinela Capanu; Daniel G Coit; Murray F Brennan; David P Kelsen; Manish A Shah
Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancer.
Journal of the American College of Surgeons 2009;208(2):173-8.
2009: Richard Carvajal; Archie N Tse; Manish A Shah; Robert A Lefkowitz; Mithat Gonen; Lisa Gilman-Rosen; Jeremy Kortmansky; David P Kelsen; Gary K Schwartz; Eileen O'Reilly
A phase II study of flavopiridol (Alvocidib) in combination with docetaxel in refractory, metastatic pancreatic cancer.
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2009;9(4):404-9.
2008: Archie N Tse; David S Klimstra; Mithat Gonen; Manish A Shah; Tahir Sheikh; Rachel Sikorski; Richard Carvajal; Janet Mui; Caroll Tipian; Eileen O'Reilly; Ki Young Chung; ROBERT G MAKI; Robert Lefkowitz; Karen T Brown; Katia Manova-Todorova; Nian Wu; Merrill J Egorin; David P Kelsen; Gary K Schwartz
A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(20):6704-11.
2008: Jaffer A Ajani; Kathryn Winter; Ritsuko Komaki; David P Kelsen; Bruce D Minsky; Zhongxing Liao; Jeffrey Bradley; Mitchel Fromm; David Hornback; Christopher G Willett
Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(28):4551-6.
2008: Geoffrey Y Ku; David H Ilson; Lawrence H Schwartz; Marinela Capanu; Eileen O'Reilly; Manish A Shah; David P Kelsen; Gary K Schwartz
Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer.
Cancer chemotherapy and pharmacology 2008;62(5):875-80.
2008: David P Kelsen
S-1 adjuvant chemotherapy for advanced gastric cancer.
Nature clinical practice. Oncology 2008;5(7):370-1.
2008: Jinru Shia; Laura H Tang; Martin R Weiser; Baruch Brenner; N Volkan Adsay; Edward B Stelow; Leonard B Saltz; Jing Qin; Ron Landmann; Gregory D Leonard; Deepti Dhall; Larissa K Temple; Jose G Guillem; Philip B Paty; David P Kelsen; Douglas Wong; David S Klimstra
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
The American journal of surgical pathology 2008;32(5):719-31.
2008: Derek G Power; David P Kelsen; Manish A Shah
The Quality of Quality-of-Life and Cost-Effectiveness Analyses.
Gastrointestinal cancer research : GCR 2008;2(2):94-5.
2008: G Y Ku; B D Minsky; Valerie W Rusch; M Bains; David P Kelsen; David H Ilson
Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(3):533-7.
2008: Timothy R Asmis; Ki Young Chung; Jerrold B Teitcher; David P Kelsen; Manish A Shah
Pneumatosis intestinalis: a variant of bevacizumab related perforation possibly associated with chemotherapy related GI toxicity.
Investigational new drugs 2008;26(1):95-6.
2008: A Duffy; Jeremy Kortmansky; Gary K Schwartz; Marinela Capanu; S Puleio; B Minsky; Leonard B Saltz; David P Kelsen; Eileen O'Reilly
A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(1):86-91.
2007: T R Asmis; Marinela Capanu; David P Kelsen; Manish A Shah
Systemic chemotherapy does not increase the risk of gastrointestinal perforation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(12):2006-8.
2007: John C Mansour; Laura H Tang; Manish A Shah; David J Bentrem; David S Klimstra; Mithat Gonen; David P Kelsen; Murray F Brennan; Daniel G Coit
Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
Annals of surgical oncology 2007;14(12):3412-8.
2007: Monica Fornier; Dana Elizabeth Rathkopf; Manish A Shah; Sujata M Patil; Eileen O'Reilly; Archie N Tse; Clifford Hudis; Robert Lefkowitz; David P Kelsen; Gary K Schwartz
Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(19):5841-6.
2007: David P Kelsen; Katryn A Winter; Leonard L Gunderson; Joanne Mortimer; Norman C. Estes; Daniel G Haller; Jaffer A Ajani; Walter Kocha; Bruce D Minsky; Jack A Roth; Christopher G Willett
Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3719-25.
2007: S E Anderson; B D Minsky; M Bains; Amanda J Hummer; David P Kelsen; David H Ilson
Combined modality chemoradiation in elderly oesophageal cancer patients.
British journal of cancer 2007;96(12):1823-7.
2007: David H Ilson; R G Wadleigh; L P Leichman; David P Kelsen
Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(5):898-902.
2007: Minaxi Jhawer; David P Kelsen; Manish A Shah
Incorporation of biologic therapies in the management of gastroesophageal cancers.
Gastrointestinal cancer research : GCR 2007;1(2 Suppl):S22-9.
2007: Baruch Brenner; Laura H Tang; Jinru Shia; David S Klimstra; David P Kelsen
Small cell carcinomas of the gastrointestinal tract: clinicopathological features and treatment approach.
Seminars in oncology 2007;34(1):43-50.
2006: Manish A Shah; Ramesh K Ramanathan; David H Ilson; Alissa Levnor; David R D'Adamo; Eileen O'Reilly; Archie N Tse; Robin Trocola; Lawrence H Schwartz; Marinela Capanu; Gary K Schwartz; David P Kelsen
Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(33):5201-6.
2006: Baruch Brenner; Manish A Shah; Martin S Karpeh; Mithat Gonen; Murray F Brennan; Daniel G Coit; David S Klimstra; Laura H Tang; David P Kelsen
A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(9):1404-11.
2006: Ki Young Chung; David P Kelsen
Adjuvant Therapy for Stage II Colorectal Cancer: Who and with What?
Current treatment options in gastroenterology 2006;9(3):272-80.
2005: David P Kelsen
Multimodality therapy of local regional esophageal cancer.
Seminars in oncology 2005;32(6 Suppl 9):S6-10.
2005: William P Tew; David P Kelsen; David H Ilson
Targeted therapies for esophageal cancer.
The oncologist 2005;10(8):590-601.
2005: Ghassan K Abou-Alfa; Eric K Rowinsky; Yehuda Z Patt; Gary K Schwartz; David P Kelsen; Sunil Sharma; Eve Siegel; Carlos R Becerra; S Gail Eckhardt; Kevie Feit; Robert L De Jager; Eileen O'Reilly
A Phase II study of intravenous exatecan administered daily for 5 days, every 3 weeks to patients with biliary tract cancers.
American journal of clinical oncology 2005;28(4):334-9.
2005: Manish A Shah; Jeremy Kortmansky; Monica Motwani; Marija Drobnjak; Mithat Gonen; Sandy Yi; Amanda Weyerbacher; Carlos Cordon-Cardo; Robert Lefkowitz; Baruch Brenner; Eileen O'Reilly; Leonard B Saltz; William Tong; David P Kelsen; Gary K Schwartz
A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridol.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(10):3836-45.
2005: Manish A Shah; David H Ilson; David P Kelsen
Thromboembolic events in gastric cancer: high incidence in patients receiving irinotecan- and bevacizumab-based therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(11):2574-6.
2005: Jeremy Kortmansky; Manish A Shah; Andreas Kaubisch; Amanda Weyerbacher; Sandy Yi; William Tong; Rebecca Sowers; Mithat Gonen; Eileen O'Reilly; Nancy Kemeny; David H Ilson; Leonard B Saltz; ROBERT G MAKI; David P Kelsen; Gary K Schwartz
Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with Fluorouracil in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1875-84.
2005: Ki Young Chung; Jinru Shia; Nancy Kemeny; Manish A Shah; Gary K Schwartz; Archie N Tse; Audrey Hamilton; Dorothy Pan; Deborah Schrag; Lawrence H Schwartz; David S Klimstra; Daniel Fridman; David P Kelsen; Leonard B Saltz
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1803-10.
2005: Marc J Gollub; Robert Lefkowitz; Chaya S Moskowitz; David H Ilson; David P Kelsen; Howard Felderman
Pelvic CT in patients with esophageal cancer.
AJR. American journal of roentgenology 2005;184(2):487-90.
2004: Baruch Brenner; Laura H Tang; David S Klimstra; David P Kelsen
Small-cell carcinomas of the gastrointestinal tract: a review.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(13):2730-9.
2004: Manish A Shah; David P Kelsen
Combined modality therapy of esophageal cancer: changes in the standard of care?
Annals of surgical oncology 2004;11(7):641-3.
2004: B Brenner; Manish A Shah; Mithat Gonen; David S Klimstra; Jinru Shia; David P Kelsen
Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases.
British journal of cancer 2004;90(9):1720-6.
2004: Gary K Schwartz; Joseph Bertino; Nancy Kemeny; Leonard B Saltz; David P Kelsen; William Tong; Mary Welch; Sandra Endres; Isaiah Dimery
Phase I trial of sequential raltitrexed followed by bolus 5-fluorouracil in patients with advanced colorectal cancer.
Anti-cancer drugs 2004;15(3):219-27.
2004: Baruch Brenner; David H Ilson; Bruce D Minsky; Manjit S Bains; William Tong; Mithat Gonen; David P Kelsen
Phase I trial of combined-modality therapy for localized esophageal cancer: escalating doses of continuous-infusion paclitaxel with cisplatin and concurrent radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):45-52.
2003: David H Ilson; Manjit S Bains; David P Kelsen; Eileen O'Reilly; Martin S Karpeh; Daniel G Coit; Valerie W Rusch; Mithat Gonen; Katie Wilson; Bruce D Minsky
Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(15):2926-32.
2003: Sibyl E Anderson; Bruce D Minsky; Manjit S Bains; David P Kelsen; David H Ilson
Combined modality therapy in esophageal cancer: the Memorial experience.
Seminars in surgical oncology 2003;21(4):228-32.
2003: Sibyl E Anderson; Eileen O'Reilly; David P Kelsen; David H Ilson
Phase II trial of 96-hour paclitaxel in previously treated patients with advanced esophageal cancer.
Cancer investigation 2003;21(4):512-6.
2002: Garrett M Nash; Leonard B Saltz; Nancy Kemeny; Bruce D Minsky; Sunil Sharma; Gary K Schwartz; David H Ilson; Eileen O'Reilly; David P Kelsen; Daniel R Nathanson; Martin R Weiser; Jose G Guillem; Douglas Wong; Alfred M Cohen; Philip B Paty
Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease.
Annals of surgical oncology 2002;9(10):954-60.
2002: Manjit S Bains; Alexander Stojadinovic; Bruce D Minsky; Valerie W Rusch; Alan D Turnbull; Robert J Korst; Robert J Ginsberg; David P Kelsen; David H Ilson
A phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: initial results.
The Journal of thoracic and cardiovascular surgery 2002;124(2):270-7.
2002: Sunil Sharma; Nancy Kemeny; David P Kelsen; David H Ilson; Eileen O'Reilly; Sara Zaknoen; C Baum; Paul Statkevich; Ellen M Hollywood; Y Zhu; Leonard B Saltz
A phase II trial of farnesyl protein transferase inhibitor SCH 66336, given by twice-daily oral administration, in patients with metastatic colorectal cancer refractory to 5-fluorouracil and irinotecan.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(7):1067-71.
2002: David H Ilson; Bruce D Minsky; David P Kelsen
Irinotecan, cisplatin, and radiation in esophageal cancer.
Oncology (Williston Park, N.Y.) 2002;16(5 Suppl 5):11-5.
2002: Gary K Schwartz; Eileen O'Reilly; David H Ilson; Leonard B Saltz; Sunil Sharma; William Tong; Peter Maslak; Maxine Stoltz; Larry Eden; Pam Perkins; Sandra Endres; John Barazzoul; David Spriggs; David P Kelsen
Phase I study of the cyclin-dependent kinase inhibitor flavopiridol in combination with paclitaxel in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):2157-70.
2002: Manish A Shah; David P Kelsen
[Postoperative adjuvant chemoradiotherapy in high risk stomach carcinoma].
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 2002;73(4):325-30.
2002: Bruce D Minsky; Thomas F Pajak; Robert J Ginsberg; Thomas M Pisansky; James Martenson; Ritsuko Komaki; Gordon Okawara; Seth A Rosenthal; David P Kelsen
INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1167-74.
2001: Alfred T Culliford; Ari D Brooks; Sunil Sharma; Leonard B Saltz; Gary K Schwartz; Eileen O'Reilly; David H Ilson; Nancy Kemeny; David P Kelsen; Jose G Guillem; Douglas Wong; Alfred M Cohen; Philip B Paty
Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer.
Annals of surgical oncology 2001;8(10):787-95.
2001: Sunil Sharma; Nancy Kemeny; Gary K Schwartz; David P Kelsen; Eileen O'Reilly; David H Ilson; John Coyle; Robert L De Jager; M P Ducharme; S Kleban; Ellen M Hollywood; Leonard B Saltz
Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeks.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12):3963-70.
2001: Gary K Schwartz; David H Ilson; Leonard B Saltz; Eileen O'Reilly; William Tong; Peter Maslak; J Werner; P Perkins; M Stoltz; David P Kelsen
Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(7):1985-92.
2001: David P Kelsen
Preoperative chemoradiotherapy for esophageal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):283-5.
2001: J Ajani; David S Ettinger; David P Kelsen; Clifford Hudis; A Kudelka; C Langer; Kenneth J Pienta; H Safran; E E Vokes; W K Yung
Radiation Therapy Oncology Group. Research Plan 2002-2006. Medical Oncology Committee.
International journal of radiation oncology, biology, physics 2001;51(3 Suppl 2):88-91.
2001: C Willett; J Ajani; David P Kelsen; E Sigurdson; R Abrams; B Berkey; M Benetz; C Crane; L Gaspar; M D Goodyear; L Gunderson; M Haddock; J Hoffmann; N Janjan; M John; L Kachnic; R Krieg; J Landry; N Meropol; B Minsky; E Mitchell; M Mohiuddin; John Moulder; R Myerson; D Noyes; T F Pajak; D Raben; William F Regine; tyvin rich; J M Robertson; A Russell; J Skibber; P Kim
Radiation Therapy Oncology Group. Research Plan 2002-2006. Gastrointestinal Cancer Committee.
International journal of radiation oncology, biology, physics 2001;51(3 Suppl 2):19-27.
2001: Eileen O'Reilly; KE Stuart; PM Sanz-Altamira; Gary K Schwartz; CM Steger; L Raeburn; Nancy Kemeny; David P Kelsen; Leonard B Saltz
A phase II study of irinotecan in patients with advanced hepatocellular carcinoma.
Cancer 2001;91(1):101-5.
2000: K Kawakami; Jan Brabender; Reginald V N Lord; Susan Groshen; Bruce D Greenwald; Mark J Krasna; Jing Yin; A Steven Fleisher; John M Abraham; David G Beer; David Sidransky; H T Huss; Tom R DeMeester; Cindy A Eads; Peter W Laird; David H Ilson; David P Kelsen; David H Harpole; M B Moore; Kathleen D Danenberg; Peter V Danenberg; Meltzer Stephen J.
Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma.
Journal of the National Cancer Institute 2000;92(22):1805-11.
2000: David P Kelsen
Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: intergroup 116.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(21 Suppl):32S-4S.
2000: David H Ilson; Arlene A Forastiere; M Arquette; F Costa; Robert T Heelan; Y Huang; David P Kelsen
A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus.
Cancer journal (Sudbury, Mass.) 2000;6(5):316-23.
2000: David P Kelsen
Surrogate endpoints in assessment of new drugs in colorectal cancer.
Lancet 2000;356(9227):353-4.
2000: David P Kelsen
Multimodality therapy of esophageal cancer: an update.
Cancer journal (Sudbury, Mass.) 2000;6 Suppl 2():S177-81.
2000: Jaffer A Ajani; David P Kelsen; D Haller; K Hargraves; D Healey
A multi-institutional phase II study of BMS-182248-01 (BR96-doxorubicin conjugate) administered every 21 days in patients with advanced gastric adenocarcinoma.
Cancer journal (Sudbury, Mass.) 2000;6(2):78-81.
2000: Chung-Tsen Hsueh; Chang-Fang Chiu; David P Kelsen; Gary K Schwartz
Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis.
Cancer chemotherapy and pharmacology 2000;45(5):389-96.
2000: David P Kelsen
Neoadjuvant therapy of squamous cell carcinoma of the esophagus.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2000;155():105-12.
1999: F Fata; Eileen O'Reilly; David H Ilson; David G Pfister; D Leffel; David P Kelsen; Gary K Schwartz; Ephraim S Casper
Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face.
Cancer 1999;86(10):2034-7.
1999: Peter C Enzinger; David H Ilson; David P Kelsen
Chemotherapy in esophageal cancer.
Seminars in oncology 1999;26(5 Suppl 15):12-20.
1999: F Fata; IG Ron; Nancy Kemeny; Eileen O'Reilly; David S Klimstra; David P Kelsen
5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma.
Cancer 1999;86(7):1129-34.
1999: David H Ilson; Leonard B Saltz; Peter C Enzinger; Y Huang; Alice B Kornblith; Marc J Gollub; Eileen O'Reilly; Gary K Schwartz; J DeGroff; G Gonzalez; David P Kelsen
Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(10):3270-5.
1999: Peter C Enzinger; David H Ilson; Leonard B Saltz; L K Martin; David P Kelsen
Phase II clinical trial of 13-cis-retinoic acid and interferon-alpha-2a in patients with advanced esophageal carcinoma.
Cancer 1999;85(6):1213-7.
1999: Kenneth Hu; Bruce D Minsky; Alfred M Cohen; David P Kelsen; Jose G Guillem; Philip P Paty; Stuart H Q Quan
30 Gy may be an adequate dose in patients with anal cancer treated with excisional biopsy followed by combined-modality therapy.
Journal of surgical oncology 1999;70(2):71-7.
1999: Bruce D Minsky; D Neuberg; David P Kelsen; Thomas M Pisansky; Robert J Ginsberg; Thomas F Pajak; M Salter; A B Benson
Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus.
International journal of radiation oncology, biology, physics 1999;43(3):517-23.
1999: Eileen O'Reilly; David H Ilson; Leonard B Saltz; Robert T Heelan; L Martin; David P Kelsen
A phase II trial of interferon alpha-2a and carboplatin in patients with advanced malignant mesothelioma.
Cancer investigation 1999;17(3):195-200.
1998: David P Kelsen; Robert J Ginsberg; Thomas F Pajak; D G Sheahan; Leonard L Gunderson; J Mortimer; Norman C. Estes; Daniel G Haller; Jaffer A Ajani; Walter Kocha; Bruce D Minsky; J A Roth
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer.
The New England journal of medicine 1998;339(27):1979-84.
1998: Leonard B Saltz; David Spriggs; Larry J Schaaf; Gary K Schwartz; David H Ilson; Nancy Kemeny; J Kanowitz; CM Steger; M Eng; P Albanese; D Semple; CK Hanover; Gary L Elfring; Langdon L Miller; David P Kelsen
Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(12):3858-65.
1998: Chung-Tsen Hsueh; David P Kelsen; Gary K Schwartz
UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(9):2201-6.
1998: Peter C Enzinger; David H Ilson; Leonard B Saltz; Eileen O'Reilly; David P Kelsen
Irinotecan and cisplatin in upper gastrointestinal malignancies.
Oncology (Williston Park, N.Y.) 1998;12(8 Suppl 6):110-3.
1998: David H Ilson; Jaffer A Ajani; Kapil N Bhalla; Arlene A Forastiere; Y Huang; P Patel; L Martin; J Donegan; R Pazdur; Carolyn E Reed; David P Kelsen
Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1826-34.
1998: F Costa; Gary K Schwartz; David P Kelsen
Adjuvant chemotherapy in gastric adenocarcinomas.
Cancer treatment and research 1998;98():41-63.
1997: David P Kelsen; R Ginsberg; M Bains; J Cooper; M Arquette; Arlene A Forastiere; David H Ilson
A phase II trial of paclitaxel and cisplatin in patients with locally advanced metastatic esophageal cancer: a preliminary report.
Seminars in oncology 1997;24(6 Suppl 19):S19-77-S19-81.
1997: Leonard B Saltz; Gary K Schwartz; David H Ilson; V Quan; David P Kelsen
A phase II study of topotecan administered five times daily in patients with advanced gastric cancer.
American journal of clinical oncology 1997;20(6):621-5.
1997: Leonard B Saltz; Nancy Kemeny; W Tong; J Harrison; R Berkery; David P Kelsen
9-Aminocamptothecin by 72-hour continuous intravenous infusion is inactive in the treatment of patients with 5-fluorouracil-refractory colorectal carcinoma.
Cancer 1997;80(9):1727-32.
1997: Martin S Karpeh; David P Kelsen
Combined modality therapy of gastric cancer.
Surgical oncology clinics of North America 1997;6(4):741-7.
1997: David H Ilson; Manjit S Bains; Robert J Ginsberg; David P Kelsen
Neoadjuvant therapy of esophageal cancer.
Surgical oncology clinics of North America 1997;6(4):723-40.
1997: K Hayashi; Ralf Metzger; Dennis Salonga; Kathleen D Danenberg; Lawrence Leichman; U Fink; A Sendler; David P Kelsen; Gary K Schwartz; Susan Groshen; H J Lenz; Peter V Danenberg
High frequency of simultaneous loss of p16 and p16beta gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach.
Oncogene 1997;15(12):1481-8.
1997: Gary K Schwartz; K Farsi; Peter Maslak; David P Kelsen; David Spriggs
Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(9):1467-72.
1997: David P Kelsen
Multimodality therapy for adenocarcinoma of the esophagus.
Gastroenterology clinics of North America 1997;26(3):635-45.
1997: A M Cohen; David P Kelsen; Leonard B Saltz; B D Minsky; H Nelson; Ridzuan Farouk; Leonard L Gunderson; Fabrizio Michelassi; Richard B Arenas; R L Schilsky; C G Willet
Adjuvant therapy for colorectal cancer.
Current problems in surgery 1997;34(8):601-76.
1997: David P Kelsen; Russell Portenoy; Howard T Thaler; Y Tao; Murray F Brennan
Pain as a predictor of outcome in patients with operable pancreatic carcinoma.
Surgery 1997;122(1):53-9.
1997: David P Kelsen
Neoadjuvant therapy of esophageal cancer.
The cancer journal from Scientific American 1997;3(3):137-9.
1997: A Grann; Bruce D Minsky; Alfred M Cohen; Leonard B Saltz; Jose G Guillem; Philip B Paty; David P Kelsen; Nancy Kemeny; David H Ilson; J Bass-Loeb
Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer.
Diseases of the colon and rectum 1997;40(5):515-22.
1997: Gary K Schwartz; D Ward; Leonard B Saltz; Ephraim S Casper; T Spiess; E Mullen; J Woodworth; R Venuti; P Zervos; A M Storniolo; David P Kelsen
A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(4):537-43.
1997: David P Kelsen; D Martin; J O'Neil; Gary K Schwartz; Leonard B Saltz; M T Sung; R von Borstel; Joseph Bertino
Phase I trial of PN401, an oral prodrug of uridine, to prevent toxicity from fluorouracil in patients with advanced cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1511-7.
1997: Bruce D Minsky; Alfred M Cohen; Warren E Enker; Leonard B Saltz; Jose G Guillem; Philip B Paty; David P Kelsen; Nancy Kemeny; David H Ilson; J Bass; J Conti
Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer.
International journal of radiation oncology, biology, physics 1997;37(2):289-95.
1997: Leonard B Saltz; David P Kelsen
Adjuvant treatment of colorectal cancer.
Annual review of medicine 1997;48():191-202.
1996: Neal J Meropol; R Pazdur; mark vincent; James Willson; David P Kelsen; H O Douglass
Phase II study of ZD1694 in patients with advanced gastric cancer.
American journal of clinical oncology 1996;19(6):628-30.
1996: Leonard B Saltz; J Kanowitz; Nancy Kemeny; Larry J Schaaf; David Spriggs; B A Staton; R Berkery; C Steger; M Eng; A Dietz; P Locker; David P Kelsen
Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, and leucovorin in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(11):2959-67.
1996: Gary K Schwartz; K Christman; Leonard B Saltz; E Casper; V Quan; J Bertino; Daniel S Martin; J Colofiore; David P Kelsen
A phase I trial of a modified, dose intensive FAMTX regimen (high dose 5-fluorouracil+doxorubicin+high dose methotrexate+leucovorin) with oral uridine rescue.
Cancer 1996;78(9):1988-95.
1996: Jaffer A Ajani; David H Ilson; David P Kelsen
Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
Seminars in oncology 1996;23(5 Suppl 12):55-8.
1996: David H Ilson; David P Kelsen
Management of esophageal cancer.
Oncology (Williston Park, N.Y.) 1996;10(9):1385-96, 1401-2; discussion 1402-8.
1996: David P Kelsen
Neoadjuvant therapy for upper gastrointestinal tract cancers.
Current opinion in oncology 1996;8(4):321-8.
1996: David P Kelsen
Adjuvant and neoadjuvant therapy for gastric cancer.
Seminars in oncology 1996;23(3):379-89.
1996: David P Kelsen; Martin S Karpeh; Gary K Schwartz; Hans Gerdes; C Lightdale; J Botet; G Lauers; David S Klimstra; Y Huang; Leonard B Saltz; V Quan; Murray F Brennan
Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(6):1818-28.
1996: DW Fennelly; David P Kelsen
The role of chemotherapy in the treatment of adenocarcinoma of the pancreas.
Hepato-gastroenterology 1996;43(8):356-62.
1996: Bruce D Minsky; D Neuberg; David P Kelsen; Thomas M Pisansky; Robert J Ginsberg; A Benson
Neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus: a preliminary analysis of the phase II intergroup trial 0122.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):149-55.
1995: David P Kelsen
Adjuvant therapy of upper gastrointestinal tract cancers.
Seminars in oncology 1995;22(6):582-99.
1995: Jaffer A Ajani; David H Ilson; David P Kelsen
The activity of paclitaxel in gastrointestinal tumors.
Seminars in oncology 1995;22(5 Suppl 12):46-50; discussion 51-3.
1995: Gary K Schwartz; Adriana Haimovitz-Friedman; S K Dhupar; Desiree Ehleiter; Peter Maslak; L Lai; F Loganzo; David P Kelsen; Zvi Fuks; Anthony P Albino
Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells.
Journal of the National Cancer Institute 1995;87(18):1394-9.
1995: David P Kelsen; David H Ilson
Chemotherapy and combined-modality therapy for esophageal cancer.
Chest 1995;107(6 Suppl):224S-232S.
1995: Pulivarthi H Rao; S Mathew; David P Kelsen; Raju S K Chaganti
Cytogenetics of gastric and esophageal adenocarcinomas. 3q deletion as a possible primary chromosomal change.
Cancer genetics and cytogenetics 1995;81(2):139-43.
1995: Jaffer A Ajani; David H Ilson; K Daugherty; David P Kelsen
Paclitaxel in the treatment of carcinoma of the esophagus.
Seminars in oncology 1995;22(3 Suppl 6):35-40.
1995: David H Ilson; M Sirott; Leonard B Saltz; Robert T Heelan; Y Huang; R Keresztes; David P Kelsen
A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
Cancer 1995;75(9):2197-202.
1995: Chaitanya R Divgi; A M Scott; L Dantis; P Capitelli; K Siler; Susan Hilton; Ronald D Finn; Nancy Kemeny; David P Kelsen; L Kostakoglu
Phase I radioimmunotherapy trial with iodine-131-CC49 in metastatic colon carcinoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(4):586-92.
1995: David P Kelsen; Russell Portenoy; Howard T Thaler; D Niedzwiecki; Steven D Passik; Y Tao; W Banks; Murray F Brennan; Kathleen M Foley
Pain and depression in patients with newly diagnosed pancreas cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(3):748-55.
1995: Y Nabeya; F Loganzo; Peter Maslak; L Lai; A R de Oliveira; Gary K Schwartz; M L Blundell; NK Altorki; David P Kelsen; A P Albino
The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents.
International journal of cancer. Journal international du cancer 1995;64(1):37-46.
1995: Anthony P Albino; J Jaehne; NK Altorki; M Blundell; C Urmacher; G Lauwers; D Niedzwiecki; David P Kelsen
Amplification of HER-2/neu gene in human gastric adenocarcinomas: correlation with primary site.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1995;21(1):56-60.
1995: Bruce D Minsky; Alfred M Cohen; Warren E Enker; David P Kelsen; Nancy Kemeny; J Frankel
Efficacy of postoperative 5-FU, high-dose leucovorin, and sequential radiation therapy for clinically resectable rectal cancer.
Cancer investigation 1995;13(1):1-7.
1994: Leonard B Saltz; B Murphy; Nancy Kemeny; J Bertino; William Tong; Deborah Keefe; Y Tzy-Jun; Y Tao; David P Kelsen; J P O'Brien
A phase I trial of intrahepatic verapamil and doxorubicin. Regional therapy to overcome multidrug resistance.
Cancer 1994;74(10):2757-64.
1994: David P Kelsen; Leonard B Saltz; Alfred M Cohen; Tzy-Jyun Yao; Warren E Enker; William Tong; Y Tao; Joseph R Bertino
A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer.
Cancer 1994;74(8):2224-33.
1994: David P Kelsen; J Ajani; David H Ilson; K Daugherty; R Pazdur
A phase II trial of paclitaxel (Taxol) in advanced esophageal cancer: preliminary report.
Seminars in oncology 1994;21(5 Suppl 8):44-8.
1994: David P Kelsen
The use of chemotherapy in the treatment of advanced gastric and pancreas cancer.
Seminars in oncology 1994;21(4 Suppl 7):58-66.
1994: David H Ilson; David P Kelsen
Combined modality therapy in the treatment of esophageal cancer.
Seminars in oncology 1994;21(4):493-507.
1994: David P Kelsen
Esophageal cancer.
Seminars in oncology 1994;21(4):401-2.
1994: Leonard B Saltz; Nancy Kemeny; Gary K Schwartz; David P Kelsen
A phase II trial of alpha-interferon and 5-fluorouracil in patients with advanced carcinoid and islet cell tumors.
Cancer 1994;74(3):958-61.
1994: Jaffer A Ajani; David H Ilson; K Daugherty; Richard Pazdur; Patrick M Lynch; David P Kelsen
Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus.
Journal of the National Cancer Institute 1994;86(14):1086-91.
1994: David H Ilson; David P Kelsen
Adjuvant postoperative therapy of gastrointestinal malignancies.
Oncology (Williston Park, N.Y.) 1994;8(7):75-83; discussion 83, 88-90, 95.
1994: Valerie W Rusch; Leonard B Saltz; Venkatraman E Seshan; Robert J Ginsberg; P McCormack; M Burt; Maurie Markman; David P Kelsen
A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(6):1156-63.
1994: David P Kelsen
The role of chemotherapy in the treatment of esophageal cancer.
Chest surgery clinics of North America 1994;4(1):173-84.
1994: Bruce D Minsky; A Cohen; Warren E Enker; David P Kelsen; Nancy Kemeny; David H Ilson; Jose G Guillem; Leonard B Saltz; J Frankel; J Conti
Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancer.
Cancer 1994;73(2):273-80.
1994: K Christman; David P Kelsen; Leonard B Saltz; P G Tarassoff
Phase II trial of gemcitabine in patients with advanced gastric cancer.
Cancer 1994;73(1):5-7.
1994: Gary K Schwartz; H Wang; N Lampen; NK Altorki; David P Kelsen; Anthony P Albino
Defining the invasive phenotype of proximal gastric cancer cells.
Cancer 1994;73(1):22-7.
1994: Ephraim S Casper; M R Green; David P Kelsen; Robert T Heelan; T D Brown; Carlos D Flombaum; B Trochanowski; P G Tarassoff
Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas.
Investigational new drugs 1994;12(1):29-34.
1993: Pulivarthi H Rao; S Mathew; G Lauwers; E Rodriguez; David P Kelsen; Raju S K Chaganti
Interphase cytogenetics of gastric and esophageal adenocarcinomas.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1993;2(4):264-8.
1993: David P Kelsen
Neoadjuvant therapy for gastrointestinal cancers.
Oncology (Williston Park, N.Y.) 1993;7(9):25-32; discussion 32, 35-6, 41.
1993: NK Altorki; Gary K Schwartz; M Blundell; B M Davis; David P Kelsen; Anthony P Albino
Characterization of cell lines established from human gastric-esophageal adenocarcinomas. Biologic phenotype and invasion potential.
Cancer 1993;72(3):649-57.
1993: Leonard B Saltz; Gregory Y Lauwers; J Wiseberg; David P Kelsen
A phase II trial of carboplatin in patients with advanced APUD tumors.
Cancer 1993;72(2):619-22.
1993: Leonard B Saltz; B Trochanowski; M Buckley; B Heffernan; D Niedzwiecki; Y Tao; David P Kelsen
Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors.
Cancer 1993;72(1):244-8.
1993: Bruce D Minsky; Alfred M Cohen; Nancy Kemeny; Warren E Enker; David P Kelsen; Leonard B Saltz; J Frankel
The efficacy of preoperative 5-fluorouracil, high-dose leucovorin, and sequential radiation therapy for unresectable rectal cancer.
Cancer 1993;71(11):3486-92.
1993: K Christman; Leonard B Saltz; Gary K Schwartz; C Friedrich; David P Kelsen
Granulocyte colony-stimulating factor: effective in ameliorating fluorouracil-based myelosuppression?
Journal of the National Cancer Institute 1993;85(10):826-7.
1993: Bruce D Minsky; Alfred M Cohen; Nancy Kemeny; Warren E Enker; David P Kelsen; Gary K Schwartz; Leonard B Saltz; J Dougherty; J Frankel; J Wiseberg
Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable rectal cancer.
International journal of radiation oncology, biology, physics 1993;25(5):821-7.
1993: Gary K Schwartz; J Jiang; David P Kelsen; Anthony P Albino
Protein kinase C: a novel target for inhibiting gastric cancer cell invasion.
Journal of the National Cancer Institute 1993;85(5):402-7.
1993: O T Atiq; David P Kelsen; M H Shiu; Leonard B Saltz; William Tong; D Niedzwiecki; B Trochanowski; S Lin; F Toomasi; Murray F Brennan
Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(3):425-33.
1992: Leonard B Saltz; David P Kelsen
Combined-modality therapy in the treatment of local-regional esophageal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(10):793-9.
1992: Ephraim S Casper; Gary K Schwartz; B Johnson; David P Kelsen
Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma.
Investigational new drugs 1992;10(4):313-6.
1992: David P Kelsen; Daniel S Martin; J Colofiore; R Sawyer; Daniel G Coit
A phase II trial of biochemical modulation using N-phosphonacetyl-L-aspartate, high-dose methotrexate, high-dose 5-fluorouracil, and leucovorin in patients with adenocarcinoma of unknown primary site.
Cancer 1992;70(7):1988-92.
1992: Bruce D Minsky; Alfred M Cohen; Nancy Kemeny; Warren E Enker; David P Kelsen; B Reichman; Leonard B Saltz; Elin R Sigurdson; J Frankel
Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(8):1218-24.
1992: Ephraim S Casper; Gary K Schwartz; David P Kelsen
Phase II trial of fazarabine (arabinofuranosyl-5-azacytidine) in patients with advanced pancreatic adenocarcinoma.
Investigational new drugs 1992;10(3):205-9.
1992: Clifford Hudis; David P Kelsen
Menogaril in the treatment of malignant mesothelioma: a phase II study.
Investigational new drugs 1992;10(2):103-6.
1992: Valerie W Rusch; D Niedzwiecki; Y Tao; C Menendez-Botet; Ann M Dnistrian; David P Kelsen; Leonard B Saltz; Maurie Markman
Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(6):1001-6.
1992: David P Kelsen; O T Atiq; Leonard B Saltz; D Niedzwiecki; D Ginn; D Chapman; Robert T Heelan; C Lightdale; V Vinciguerra; Murray F Brennan
FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(4):541-8.
1992: David P Kelsen; D Lovett; J Wong; Leonard B Saltz; M Buckley; P Murray; Robert T Heelan; C Lightdale
Interferon alfa-2a and fluorouracil in the treatment of patients with advanced esophageal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(2):269-74.
1992: Bruce D Minsky; Alfred M Cohen; Nancy Kemeny; Warren E Enker; David P Kelsen; B Reichman; Leonard B Saltz; Elin R Sigurdson; J Frankel
Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(1):79-84.
1992: Bruce D Minsky; Alfred M Cohen; Warren E Enker; David P Kelsen; Nancy Kemeny; B Riechman; Leonard B Saltz; Elin R Sigurdson; J Frankel
Phase I trial of postoperative 5-FU, radiation therapy, and high dose leucovorin for resectable rectal cancer.
International journal of radiation oncology, biology, physics 1992;22(1):139-45.
1992: Maurie Markman; David P Kelsen
Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma.
Journal of cancer research and clinical oncology 1992;118(7):547-50.
1991: David P Kelsen
Adjuvant therapy of upper gastrointestinal tract cancers.
Seminars in oncology 1991;18(6):543-59.
1991: John Crown; Ephraim S Casper; J Botet; P Murray; David P Kelsen
Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(9):1682-6.
1991: David P Kelsen; Clifford Hudis; D Niedzwiecki; J Dougherty; E Casper; J Botet; V Vinciguerra; R Rosenbluth
A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma.
Cancer 1991;68(5):965-9.
1991: David P Kelsen; O T Atiq
Therapy of upper gastrointestinal tract cancers.
Current problems in cancer 1991;15(5):235-94.
1991: Bruce D Minsky; A M Cohen; Warren E Enker; David P Kelsen; Nancy Kemeny; E Sigurdson
Adjuvant postoperative radiation therapy for resectable rectal cancer.
Radiation medicine 1991;9(4):153-8.
1991: Bruce D Minsky; Nancy Kemeny; Alfred M Cohen; Warren E Enker; David P Kelsen; B Reichman; Leonard B Saltz; Elin R Sigurdson; J Frankel
Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer.
Cancer 1991;67(11):2859-66.
1991: D Lovett; David P Kelsen; Mario A Eisenberger; C Houston
A phase II trial of carboplatin and vinblastine in the treatment of advanced squamous cell carcinoma of the esophagus.
Cancer 1991;67(2):354-6.
1990: Nancy Kemeny; Anas Younes; K Seiter; David P Kelsen; P Sammarco; L Adams; S Derby; P Murray; C Houston
Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma. Assessment of activity and toxicity.
Cancer 1990;66(12):2470-5.
1990: Leonard B Saltz; David P Kelsen
A phase I trial of cisplatin in hypertonic saline and escalating doses of 5-fluorouracil by continuous intravenous infusion in patients with advanced malignancies.
Cancer 1990;66(8):1688-91.
1990: Jane Houldsworth; Carlos Cordon-Cardo; Marc Ladanyi; David P Kelsen; Raju S K Chaganti
Gene amplification in gastric and esophageal adenocarcinomas.
Cancer research 1990;50(19):6417-22.
1990: E Rodriguez; Pulivarthi H Rao; Marc Ladanyi; NK Altorki; Anthony P Albino; David P Kelsen; Suresh C Jhanwar; Raju S K Chaganti
11p13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinomas.
Cancer research 1990;50(19):6410-6.
1990: Nancy Kemeny; B Childs; W Larchian; K Rosado; David P Kelsen
A phase II trial of recombinant tumor necrosis factor in patients with advanced colorectal carcinoma.
Cancer 1990;66(4):659-63.
1990: H van Dekken; J G Pizzolo; David P Kelsen; M R Melamed
Targeted cytogenetic analysis of gastric tumors by in situ hybridization with a set of chromosome-specific DNA probes.
Cancer 1990;66(3):491-7.
1990: D Ginn; David P Kelsen; Mario A Eisenberger; Robert T Heelan; G Magill
Phase II trial of carboplatin and vinblastine in adenocarcinoma of the stomach.
Investigational new drugs 1990;8(3):321-4.
1990: David P Kelsen; Bruce D Minsky; M Smith; J Beitler; D Niedzwiecki; D Chapman; Manjit S Bains; M Burt; Robert T Heelan; B Hilaris
Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(8):1352-61.
1990: David M Nanus; David P Kelsen; I R Mentle; NK Altorki; Anthony P Albino
Infrequent point mutations of ras oncogenes in gastric cancers.
Gastroenterology 1990;98(4):955-60.
1990: A S Goldenberg; David P Kelsen; J Dougherty; G Magill
Phase II study of CHIP chemotherapy in advanced adenocarcinomas of the upper gastrointestinal tract.
Investigational new drugs 1990;8(1):71-5.
1990: S A Kambhu; David P Kelsen; J Fiore; D Niedzwiecki; D Chapman; V Vinciguerra; R Rosenbluth
Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results.
American journal of clinical oncology 1990;13(1):55-60.
1990: David P Kelsen; Manjit S Bains; M Burt
Neoadjuvant chemotherapy and surgery of cancer of the esophagus.
Seminars in surgical oncology 1990;6(5):268-73.
1990: Dean F Bajorin; David P Kelsen
A phase I trial of combination chemotherapy employing carboplatin, vinca alkaloids, with or without bleomycin in patients with advanced malignant tumors.
Cancer investigation 1990;8(2):135-41.
1989: J B Dougherty; David P Kelsen; Nancy Kemeny; G Magill; J Botet; D Niedzwiecki
Advanced pancreatic cancer: a phase I-II trial of cisplatin, high-dose cytarabine, and caffeine.
Journal of the National Cancer Institute 1989;81(22):1735-8.
1989: David P Kelsen
Neoadjuvant therapy of esophageal cancer.
Canadian journal of surgery. Journal canadien de chirurgie 1989;32(6):410-4.
1989: G L Nichols; David P Kelsen
Small cell carcinoma of the esophagus. The Memorial Hospital experience 1970 to 1987.
Cancer 1989;64(7):1531-3.
1989: C J Lightdale; J F Botet; David P Kelsen; A D Turnbull; Murray F Brennan
Diagnosis of recurrent upper gastrointestinal cancer at the surgical anastomosis by endoscopic ultrasound.
Gastrointestinal endoscopy 1989;35(5):407-12.
1989: David M Nanus; David P Kelsen; D Niedzwiecki; D Chapman; Murray F Brennan; E Cheng; M Melamed
Flow cytometry as a predictive indicator in patients with operable gastric cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(8):1105-12.
1988: David M Nanus; David P Kelsen; R Lipperman; Mario A Eisenberger
Phase II trial of ifosfamide in epidermoid carcinoma of the esophagus: unexpectant severe toxicity.
Investigational new drugs 1988;6(3):239-41.
1988: David P Kelsen
Chemotherapy of gastric cancer: a review.
Israel journal of medical sciences 1988;24(9-10):557-61.
1988: J Frame; David P Kelsen; Nancy Kemeny; E Cheng; D Niedzwiecki; Robert T Heelan; R Lippermann
A phase II trial of streptozotocin and adriamycin in advanced APUD tumors.
American journal of clinical oncology 1988;11(4):490-5.
1988: Howard I Scher; B Shank; Robert A Chapman; N Geller; C Pinsky; R Gralla; David P Kelsen; George J Bosl; R Golbey; G Petroni
Randomized trial of combined modality therapy with and without thymosin fraction V in the treatment of small cell lung cancer.
Cancer research 1988;48(6):1663-70.
1988: B Reichman; Maurie Markman; T Hakes; Nancy Kemeny; David P Kelsen; William J Hoskins; S Rubin; J L Lewis
Phase I trial of concurrent intraperitoneal and continuous intravenous infusion of fluorouracil in patients with refractory cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(1):158-62.
1988: A Goldenberg; David P Kelsen; Pasquale Benedetto
Phase II trial of mitoxantrone in advanced gastric cancer.
Oncology 1988;45(4):273-5.
1987: Dean F Bajorin; David P Kelsen; D M Mintzer
Phase II trial of mitomycin in malignant mesothelioma.
Cancer treatment reports 1987;71(9):857-8.
1987: D M Nanus; David P Kelsen; D G Clark
Radiation-induced angiosarcoma.
Cancer 1987;60(4):777-9.
1987: David P Kelsen
Preoperative chemotherapy in esophageal carcinoma.
World journal of surgery 1987;11(4):433-8.
1987: Mark G Kris; R J Gralla; M T Burke; J J Fiore; David P Kelsen; L D Marks; Robert T Heelan
Phase II trial of esorubicin in patients with advanced non-small cell lung cancer.
Cancer treatment reports 1987;71(7-8):783-4.
1987: Mark G Kris; R J Gralla; M T Burke; L D Berkowitz; L D Marks; David P Kelsen; Robert T Heelan
Phase II trial of oral piritrexim (BW301U) in patients with stage III non-small cell lung cancer.
Cancer treatment reports 1987;71(7-8):763-4.
1987: David P Kelsen
Multimodality therapy of esophageal carcinoma: still an experimental approach.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(4):530-1.
1987: David P Kelsen; J Buckner; A Einzig; G Magill; Robert T Heelan; V Vinciguerra
Phase II trial of cisplatin and etoposide in adenocarcinomas of the upper gastrointestinal tract.
Cancer treatment reports 1987;71(3):329-30.
1987: David P Kelsen; J Fiore; Robert T Heelan; E Cheng; G Magill
Phase II trial of etoposide in APUD tumors.
Cancer treatment reports 1987;71(3):305-7.
1986: J P O'Connell; Mark G Kris; R J Gralla; S Groshen; A Trust; J J Fiore; David P Kelsen; Robert T Heelan; R B Golbey
Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(11):1604-14.
1986: Dean F Bajorin; David P Kelsen; Robert T Heelan
Phase II trial of dichloromethotrexate in epidermoid carcinoma of the esophagus.
Cancer treatment reports 1986;70(10):1245-6.
1986: Mark G Kris; R J Gralla; Michael S Wertheim; David P Kelsen; J P O'Connell; M T Burke; J J Fiore; I R Cibas; Robert T Heelan
Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer.
Cancer treatment reports 1986;70(9):1091-6.
1986: David P Kelsen; R Fein; C Coonley; Robert T Heelan; Manjit S Bains
Cisplatin, vindesine, and mitoguazone in the treatment of esophageal cancer.
Cancer treatment reports 1986;70(2):255-9.
1986: V S Swaroop; David P Kelsen
Chemotherapy of gastric cancer.
Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 1986;5(1):5-6.
1986: David P Kelsen; B Hilaris; N Martini
Neoadjuvant chemotherapy and surgery of cancer of the esophagus.
Seminars in surgical oncology 1986;2(3):170-6.
1985: A Einzig; David P Kelsen; E Cheng; P Sordillo; Robert T Heelan; R Winn; G Magill
Phase II trial of carboplatin in patients with adenocarcinomas of the upper gastrointestinal tract.
Cancer treatment reports 1985;69(12):1453-4.
1985: R Fein; David P Kelsen; N Geller; Manjit S Bains; P McCormack; Murray F Brennan
Adenocarcinoma of the esophagus and gastroesophageal junction. Prognostic factors and results of therapy.
Cancer 1985;56(10):2512-8.
1985: C Sternberg; David P Kelsen; M Dukeman; L Leichman; Robert T Heelan
Carboplatin: a new platinum analog in the treatment of epidermoid carcinoma of the esophagus.
Cancer treatment reports 1985;69(11):1305-7.
1985: Mark G Kris; R J Gralla; R A Clark; L B Tyson; J J Fiore; David P Kelsen; S Groshen
Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone.
Cancer treatment reports 1985;69(11):1257-62.
1985: Mark G Kris; R J Gralla; R A Clark; L B Tyson; J P O'Connell; Michael S Wertheim; David P Kelsen
Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(10):1379-84.
1985: Mark G Kris; R J Gralla; David P Kelsen; E S Casper; M T Burke; J J Fiore; I R Cibas; Robert T Heelan
Phase II trial of oral 4-demethoxydaunorubicin in patients with non-small cell lung cancer.
American journal of clinical oncology 1985;8(5):377-9.
1985: C J Coonley; P Schauer; David P Kelsen; P Sordillo; A G Huvos
Chemotherapy of metastatic sweat gland carcinoma. A retrospective review.
American journal of clinical oncology 1985;8(4):307-11.
1985: D M Mintzer; David P Kelsen; D Frimmer; Robert T Heelan; R Gralla
Phase II trial of high-dose cisplatin in patients with malignant mesothelioma.
Cancer treatment reports 1985;69(6):711-2.
1985: J J Fiore; David P Kelsen; R J Gralla; E S Casper; G Magill; E Cheng; M Ochoa
Adenocarcinoma of unknown primary origin: treatment with vindesine and doxorubicin.
Cancer treatment reports 1985;69(6):591-4.
1985: Mark G Kris; R J Gralla; L A Kalman; David P Kelsen; E S Casper; M T Burke; S Groshen; I R Cibas; R Bagin; Robert T Heelan
Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment.
Cancer treatment reports 1985;69(4):387-95.
1985: Mark G Kris; R J Gralla; David P Kelsen; E S Casper; M T Burke; J J Fiore; I R Cibas; Robert T Heelan
Trial of vindesine plus mitomycin in stage-3 non-small cell lung cancer. An active regimen for outpatient treatment.
Chest 1985;87(3):368-72.
1985: David P Kelsen; N Alcock; C W Young
Cisplatin nephrotoxicity. Correlation with plasma platinum concentrations.
American journal of clinical oncology 1985;8(1):77-80.
1985: Mark G Kris; R J Gralla; L B Tyson; R A Clark; David P Kelsen; L K Reilly; S Groshen; George J Bosl; L A Kalman
Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients.
Cancer 1985;55(3):527-34.
1985: David P Kelsen
Chemotherapy of esophageal cancer.
European journal of cancer & clinical oncology 1985;21(1):5-7.
1985: A I Einzig; R J Gralla; Brian Leyland-Jones; David P Kelsen; I Cibas; E Lewis; E Greenberg
Phase I study of elliptinium (2-N-methyl-9-hydroxyellipticinium).
Cancer investigation 1985;3(3):235-41.
1985: David P Kelsen
Chemotherapy-based multi-modality therapy of esophageal cancer.
Progress in clinical and biological research 1985;201():241-52.
1984: C J Coonley; Manjit S Bains; B Hilaris; Robert A Chapman; David P Kelsen
Cisplatin and bleomycin in the treatment of esophageal carcinoma. A final report.
Cancer 1984;54(11):2351-5.
1984: A Einzig; David P Kelsen; E Cheng; P Sordillo; V Raymond; G Magill
Phase II study of 4-demethoxydaunorubicin in patients with adenocarcinoma of the upper gastrointestinal tract.
Cancer treatment reports 1984;68(11):1415-6.
1984: J Zeffren; A Yagoda; David P Kelsen; R Winn
Phase I-II trial of a 5-day continuous infusion of vinblastine sulfate.
Anticancer research 1984;4(6):411-3.
1984: David P Kelsen; Manjit S Bains; B Hilaris; N Martini
Combined-modality therapy of esophageal cancer.
Seminars in oncology 1984;11(2):169-77.
1984: David P Kelsen
Chemotherapy of esophageal cancer.
Seminars in oncology 1984;11(2):159-68.
1984: H Scher; Robert A Chapman; David P Kelsen; R Gralla; R Wittes
Phase II trial of mitoguazone in patients with relapsed small cell carcinoma of the lung.
Cancer treatment reports 1984;68(3):561-2.
1984: Howard I Scher; David P Kelsen; L Kalman; L Jones; J Burchenal; R Gralla
Phase-II trial of 1,2-diaminocyclohexane (4-carboxyphthalato) platinum (II) (DACCP) in non-small cell lung cancer.
Cancer chemotherapy and pharmacology 1984;12(2):101-3.
1984: R J Gralla; L B Tyson; L A Bordin; R A Clark; David P Kelsen; Mark G Kris; L B Kalman; S Groshen
Antiemetic therapy: a review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol.
Cancer treatment reports 1984;68(1):163-72.
1983: David P Kelsen; B Hilaris; C Coonley; Robert A Chapman; M Lesser; M Dukeman; Robert T Heelan; Manjit S Bains
Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma.
The American journal of medicine 1983;75(4):645-52.
1983: David P Kelsen; Robert T Heelan; C Coonley; Manjit S Bains; N Martini; B Hilaris; R B Golbey
Clinical and pathological evaluation of response to chemotherapy in patients with esophageal carcinoma.
American journal of clinical oncology 1983;6(5):539-46.
1983: L A Kalman; M B Stoopler; E S Casper; David P Kelsen; Mark G Kris; R J Gralla
Phase II trial of PCNU in non-small cell lung cancer.
Cancer treatment reports 1983;67(9):837.
1983: David P Kelsen; R Gralla; E Cheng; N Martini
Vindesine in the treatment of malignant mesothelioma: a phase II study.
Cancer treatment reports 1983;67(9):821-2.
1983: L A Kalman; Mark G Kris; R J Gralla; David P Kelsen; E S Casper; Robert T Heelan; R E Wittes
Phase II trial of 4'-epi-doxorubicin in patients with non-small cell lung cancer.
Cancer treatment reports 1983;67(6):591-2.
1983: David P Kelsen; G B Magill; E Cheng; M Dukeman; P Sordillo; Robert T Heelan; A Yagoda
Phase II trial of etoposide in adenocarcinomas of the upper gastrointestinal tract.
Cancer treatment reports 1983;67(5):509-10.
1983: C J Coonley; Manjit S Bains; Robert T Heelan; M Dukeman; David P Kelsen
Phase II study of etoposide in the treatment of esophageal carcinoma.
Cancer treatment reports 1983;67(4):397-8.
1983: L M Itri; R J Gralla; David P Kelsen; Robert A Chapman; E S Casper; D W Braun; J E Howard; R Golbey; Robert T Heelan
Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancer.
Cancer 1983;51(6):1050-5.
1983: E S Casper; David P Kelsen; N W Alcock; J L Lewis
Ip cisplatin in patients with malignant ascites: pharmacokinetic evaluation and comparison with the iv route.
Cancer treatment reports 1983;67(3):235-8.
1982: R B Natale; A Yagoda; David P Kelsen; R J Gralla; R C Watson
Phase II trial of PALA in hypernephroma and urinary bladder cancer.
Cancer treatment reports 1982;66(12):2091-2.
1982: David P Kelsen
Treatment of advanced esophageal cancer.
Cancer 1982;50(11 Suppl):2576-81.
1982: David P Kelsen; Howard I Scher; N Alcock; Brian Leyland-Jones; A Donner; L Williams; G Greene; J H Burchenal; C Tan; F S Philips; C W Young
Phase I clinical trial and pharmacokinetics of 4'-carboxyphthalato(1,2-diaminocyclohexane)platinum(II).
Cancer research 1982;42(11):4831-5.
1982: M S Bains; David P Kelsen; E J Beattie; N Martini
Treatment of esophageal carcinoma combined preoperative chemotherapy.
The Annals of thoracic surgery 1982;34(5):521-8.
1982: David P Kelsen; Robert A Chapman; Manjit S Bains; Robert T Heelan; M Dukeman; R Golbey
Phase II study of methyl-GAG in the treatment of esophageal carcinoma.
Cancer treatment reports 1982;66(6):1427-9.
1982: P P Sordillo; G B Magill; R J Gralla; David P Kelsen
Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (m-AMSA) in patients with gastric adenocarcinoma.
American journal of clinical oncology 1982;5(3):273-5.
1982: David P Kelsen; J Hoffman; N Alcock; E Cheng; E Bailey; C Young; R Golbey; J Fortner
Pharmacokinetics of cisplatin regional hepatic infusions.
American journal of clinical oncology 1982;5(2):173-8.
1982: David P Kelsen; A Yagoda; R Warrell; Robert A Chapman; R Whittes; R J Gralla; E Casper; C W Young
Phase II trials of methylglyoxal-bis (guanylhydrazone).
American journal of clinical oncology 1982;5(2):221-5.
1982: David P Kelsen; Manjit S Bains; B Hilaris; Robert A Chapman; P McCormack; J Alexander; S Hopfan; N Martini
Combination chemotherapy of esophageal carcinoma using cisplatin, vindesine, and bleomycin.
Cancer 1982;49(6):1174-7.
1982: L M Itri; R J Gralla; Robert A Chapman; David P Kelsen; E S Casper; R B Golbey
Phase II trial of VP-16-213 in non-small-cell lung cancer.
American journal of clinical oncology 1982;5(1):45-7.
1982: David P Kelsen; R Gralla; M Stoopler; E Casper; E Cheng; C Kosloff; R Golbey
Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
Cancer treatment reports 1982;66(2):247-51.
1982: Robert A Chapman; L Itri; R Gralla; David P Kelsen; E Casper; R Golbey
Phase II trial of VP16-213 in non-small cell lung cancer (NSCLC).
Cancer chemotherapy and pharmacology 1982;7(2-3):205-7.
1981: R J Gralla; L M Itri; S E Pisko; A E Squillante; David P Kelsen; D W Braun; L A Bordin; T J Braun; C W Young
Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
The New England journal of medicine 1981;305(16):905-9.
1981: R J Gralla; E S Casper; David P Kelsen; D W Braun; M E Dukeman; N Martini; C W Young; R B Golbey
Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules.
Annals of internal medicine 1981;95(4):414-20.
1981: R J Gralla; R E Wittes; E S Casper; David P Kelsen; E Cvitkovic; G B Magill; Susan E Krown; R B Golbey
Chemotherapy of non-small cell lung cancer: clinical trials at the Memorial Sloan-Kettering Cancer Center.
World journal of surgery 1981;5(5):667-73.
1981: David P Kelsen; Manjit S Bains; Robert A Chapman; R Golbey
Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma.
Cancer treatment reports 1981;65(9-10):781-5.
1981: David P Kelsen; R Ahuja; S Hopfan; M S Bains; C Kosloff; N Martini; P McCormack; R B Golbey
Combined modality therapy of esophageal carcinoma.
Cancer 1981;48(1):31-7.
1981: E S Casper; R J Gralla; G R Lynch; B R Jones; T M Woodcock; C Gordon; David P Kelsen; C W Young
Phase I and pharmacological studies of pentamethylmelamine administered by 24-hour intravenous infusion.
Cancer research 1981;41(4):1402-6.
1981: David P Kelsen; P Ribaud; N Alcock; J H Burchenal; C W Young; G Mathe
Pharmacokinetics of Malonato (1,2 diaminocyclohexane) platinum.
Cancer clinical trials 1981;4(4):429-31.
1981: G R Lynch; R J Gralla; David P Kelsen; E S Casper; M B Stoopler; R B Golbey
Phase II evaluation of metoprine in patients with non-small-cell lung carcinoma.
Cancer clinical trials 1981;4(3):273-6.
1981: Robert A Chapman; David P Kelsen; R Gralla; L Itri; E Casper; C Young; R Golbey
Phase II trial of methylglyoxal-bis-(guanylhydrazone) in non-small-cell lung cancer.
Cancer clinical trials 1981;4(4):389-91.
1981: David P Kelsen
Advances in chemotherapy of esophageal cancer.
Clinical bulletin 1981;11(3):131-8.
1980: David P Kelsen; N Alcock; S Yeh; J Brown; C Young
Pharmacokinetics of gallium nitrate in man.
Cancer 1980;46(9):2009-13.
1980: David P Kelsen; E Weston; Robert C Kurtz; E Cvitkovic; P Lieberman; R B Golbey
Small-cell carcinoma of the esophagus: treatment by chemotherapy alone.
Cancer 1980;45(7):1558-61.
1980: E S Casper; R J Gralla; David P Kelsen; A Houghton; R B Golbey; C W Young
Phase II evaluation of N-(phosphonacetyl)-L-aspartic acid (PALA) in patients with non-small cell carcinoma of the lung.
Cancer treatment reports 1980;64(4-5):705-7.
1980: E S Casper; R J Gralla; David P Kelsen; R B Natale; P Sordillo; A Houghton
Phase II evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with non-small cell lung cancer.
Cancer treatment reports 1980;64(2-3):345-7.
1980: P Ribaud; David P Kelsen; N Alcock; E Garcia-Giralt; P Dubouch; C C Young; F M Muggia; J H Burchenal; G Mathé
Preclinical and phase I studies of malonatoplatinum.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1980;74():156-62.
1979: E S Casper; R J Gralla; David P Kelsen; E Cvitkovic; R B Golbey
Phase II study of high-dose cis-dichlorodiammineplatinum(II) in the treatment of non-small cell lung cancer.
Cancer treatment reports 1979;63(11-12):2107-9.
1979: E S Casper; David P Kelsen; N W Alcock; C W Young
Platinum concentrations in bile and plasma following rapid and 6-hour infusions of cis-dichlorodiammineplatinum(II).
Cancer treatment reports 1979;63(11-12):2023-5.
1979: David P Kelsen; M Bains; E Cvitkovic; R Golbey
Vindesine in the treatment of esophageal carcinoma: a phase II study.
Cancer treatment reports 1979;63(11-12):2019-21.
1979: David P Kelsen; T S Gee; Raju S K Chaganti
Philadelphia chromosome positive chronic myelogenous leukemia developing in a patient with acute lymphoblastic leukemia.
Cancer 1979;43(5):1782-7.
1978: David P Kelsen; E Cvitkovic; M Bains; M Shils; J Howard; S Hopfan; R B Golbey
cis-Dichlorodiammineplatinum(II) and bleomycin in the treatment of esophageal carcinomas.
Cancer treatment reports 1978;62(7):1041-6.
1978: S G Kelsen; David P Kelsen; B F Fleeger; R C Jones; T Rodman
Emergency room assessment and treatment of patients with acute asthma. Adequacy of the conventional approach.
The American journal of medicine 1978;64(4):622-8.
1977: S G Kelsen; M McGuckin; David P Kelsen; N S Cherniack
Airborne contamination of fine-particle nebulizers.
JAMA : the journal of the American Medical Association 1977;237(21):2311-4.